![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/03/2892323/0/en/Aeterna-Zentaris-and-Ceapro-Complete-Merger-Transaction.html
https://www.globenewswire.com/news-release/2024/05/29/2889961/0/en/Ceapro-Inc-Reports-Financial-Results-for-First-Quarter-2024-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/29/2871275/0/en/Ceapro-Inc-Reports-2023-Financial-Results-and-Operational-Highlights.html
https://www.globenewswire.com//news-release/2024/03/12/2844946/0/en/Aeterna-Zentaris-and-Ceapro-Merger-Approved-by-Securityholders-at-Special-Meetings.html
https://www.globenewswire.com//news-release/2024/02/23/2834482/0/en/Ceapro-Provides-Business-Update-on-Progress-of-Ongoing-Development-Programs-Technology-and-Cosmeceutical-Base-Business.html
https://www.globenewswire.com//news-release/2024/02/15/2830459/0/en/Ceapro-Inc-Announces-the-Mailing-of-Meeting-Materials-in-Connection-With-the-Special-Meeting-of-Securityholders-to-Approve-Merger-With-Aeterna-Zentaris.html
https://www.globenewswire.com//news-release/2023/12/14/2796184/0/en/Aeterna-Zentaris-and-Ceapro-Announce-Merger-of-Equals-to-Create-a-Diversified-Biopharmaceutical-Company.html
https://www.globenewswire.com//news-release/2023/12/13/2795574/0/en/Ceapro-Inc-Announces-Dosing-of-First-Patients-in-Phase-1-2a-Study-Assessing-Flagship-Product-Avenanthramides-for-Potential-Applications-in-Inflammation-Based-Diseases.html
https://www.globenewswire.com//news-release/2023/11/29/2787836/0/en/Ceapro-Inc-Reports-2023-Third-Quarter-and-Nine-Month-Financial-Results-and-Operational-Highlights.html
https://www.globenewswire.com//news-release/2023/11/27/2786260/0/en/Ceapro-Inc-Initiates-Phase-1-2a-Study-Assessing-Its-Flagship-Product-Avenanthramides-for-Potential-Applications-in-Inflammation-Based-Diseases.html